mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.07 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |